RightFit Trial Directory

Lung Cancer clinical trials in Maumee, OH

7 recruiting lung cancer studies with a site in Maumee, OH.

All trials in Maumee, OH · All Lung Cancer trials

RecruitingPhase 1NCT07814248

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

Sponsor: TwoStep Therapeutics, Inc.

Maumee, OH · +2 more sites

RecruitingPhase not listedNCT07124000

DESTINY-PANTUMOUR04

Sponsor: AstraZeneca

Canton, OH · Maumee, OH · +16 more sites

RecruitingPhase 3NCT06357533

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Sponsor: AstraZeneca

Cincinnati, OH · Columbus, OH · Maumee, OH · +60 more sites

RecruitingPhase 1 / Phase 2NCT07491497

A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

Sponsor: TRIANA Biomedicines, Inc.

Cincinnati, OH · Maumee, OH · +12 more sites

RecruitingPhase 1 / Phase 2NCT05379985

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Sponsor: Revolution Medicines, Inc.

Cincinnati, OH · Maumee, OH · +19 more sites

RecruitingPhase 1 / Phase 2NCT07030257

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Sponsor: Tasca Therapeutics

Cleveland, OH · Maumee, OH · +11 more sites

RecruitingPhase not listedNCT05236114

GEMINI-NSCLC: NSCLC Biomarker Study

Sponsor: Tempus AI

Canton, OH · Cincinnati, OH · Columbus, OH · +55 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.